# Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle

> **NCT03079401** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Boston Children's Hospital** · enrollment: 19 (actual)

## Conditions studied

- Hypoplastic Left Heart Syndrome
- Atrioventricular Canal

## Interventions

- **BIOLOGICAL:** MPC; rexlemestrocel-L

## Key facts

- **NCT ID:** NCT03079401
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-27
- **Primary completion:** 2022-12-19
- **Final completion:** 2024-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079401, "Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03079401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*